Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia

被引：0
作者：
Takuya Maeda
Azusa Hiura
Jiro Uehara
Rino Toyoshima
Tomoe Nakagawa
Koji Yoshino
机构：
[1] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Dermatologic Oncology
来源：
European Journal of Dermatology | 2021年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：662 / 664
页数：2
相关论文
共 50 条
[1]   Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia [J].
Maeda, Takuya ;
Hiura, Azusa ;
Uehara, Jiro ;
Toyoshima, Rino ;
Nakagawa, Tomoe ;
Yoshino, Koji .
EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (05) :662-664
[2]   Real-world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma [J].
Takahashi, Akira ;
Namikawa, Kenjiro ;
Ogata, Dai ;
Nakano, Eiji ;
Jinnai, Shunichi ;
Nakama, Kenta ;
Tsutsui, Keita ;
Muto, Yusuke ;
Mizuta, Haruki ;
Yamazaki, Naoya .
JOURNAL OF DERMATOLOGY, 2020, 47 (11) :1267-1275
[3]   Real-World Evidence of Ipilimumab Plus Nivolumab Combination Therapy in Patients with Malignant Pleural Mesothelioma [J].
Kondo, T. ;
Otsuki, T. ;
Kato, M. ;
Murata, T. ;
Mori, M. ;
Ota, H. ;
Wakita, H. ;
Kandori, T. ;
Kiyota, J. ;
Higashiyama, T. ;
Tokuda, M. ;
Tada, A. ;
Negi, Y. ;
Horio, D. ;
Fujimoto, D. ;
Mikami, K. ;
Takahashi, R. ;
Minami, T. ;
Kuribayashi, K. ;
Kijima, T. .
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) :S276-S277
[4]   HEALTHCARE COST COMPARISON ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA [J].
Potluri, R. ;
Bhandari, H. ;
Ranjan, S. ;
Moshyk, A. ;
Kotapati, S. .
VALUE IN HEALTH, 2019, 22 :S72-S73
[5]   Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma [J].
Ravi Potluri ;
Sandip Ranjan ;
Hitesh Bhandari ;
Helen Johnson ;
Andriy Moshyk ;
Srividya Kotapati .
Experimental Hematology & Oncology, 8
[6]   Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma [J].
Potluri, Ravi ;
Ranjan, Sandip ;
Bhandari, Hitesh ;
Johnson, Helen ;
Moshyk, Andriy ;
Kotapati, Srividya .
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (1)
[7]   Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma [J].
Parakh, Sagun ;
Randhawa, Manreet ;
Nguyen, Bella ;
Warburton, Lydia ;
Hussain, Mohammad Akhtar ;
Cebon, Jonathan ;
Millward, Michael ;
Yip, Desmond ;
Ali, Sayed .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (01) :26-30
[8]   Real-world outcomes of ipilimumab plus nivolumab for advanced melanoma in the Netherlands [J].
van Zeijl, M. C. T. ;
Wouters, M. W. J. M. ;
van den Eertwegh, A. J. M. ;
de Wreede, L. C. ;
Aarts, M. J. B. ;
van Akkooi, A. C. J. ;
Van den Berkmortel, F. W. P. J. ;
de Groot, J. W. ;
Boers-Sonderen, M. J. ;
van der Hoeven, J. J. M. ;
Hospers, G. A. P. ;
Kapiteijn, E. ;
Piersma, D. ;
van Rijn, R. S. ;
Suijkerbuijk, K. P. M. ;
Ten Tije, A. J. ;
Van der Veldt, A. A. M. ;
Vreugdenhil, G. ;
Haanen, J. B. A. G. .
ANNALS OF ONCOLOGY, 2019, 30
[9]   Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study [J].
Oka, Yurie ;
Matsumoto, Jun ;
Takeda, Tatsuaki ;
Iwata, Naohiro ;
Niimura, Takahiro ;
Ozaki, Aya Fukuma ;
Bekku, Kensuke ;
Hamano, Hirofumi ;
Araki, Motoo ;
Ishizawa, Keisuke ;
Zamami, Yoshito ;
Ariyoshi, Noritaka .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (03) :745-750
[10]   COMPARISON OF HEALTHCARE COSTS IN FRANCE OF COMBINATION NIVOLUMAB AND IPILIMUMAB TREATMENT VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA [J].
Bregman, B. ;
Moshyk, A. ;
Johnson, H. M. ;
Potluri, R. ;
Bhandari, H. ;
Ranjan, S. .
VALUE IN HEALTH, 2020, 23 :S441-S441
12345